Triage Test for Tuberculosis Spots Infections Within an Hour
Triage Test for Tuberculosis Spots Infections Within an Hour
An early-stage, blood-based assay shows potential as a method for sorting patients with suspected TB from those with other respiratory illnesses.
Triage Test for Tuberculosis Spots Infections Within an Hour
Triage Test for Tuberculosis Spots Infections Within an Hour

An early-stage, blood-based assay shows potential as a method for sorting patients with suspected TB from those with other respiratory illnesses.

An early-stage, blood-based assay shows potential as a method for sorting patients with suspected TB from those with other respiratory illnesses.

molecular diagnostics

Q&A: Confirming Next-Gen Sequencing Results with Sanger
Tracy Vence | Oct 11, 2016
Ambry Genetics CEO Aaron Elliott discusses his team’s recent analysis of 20,000 clinical next-generation sequencing panels.
Who Is Immune to Zika?
Amanda B. Keener | Oct 11, 2016
Researchers tap into ongoing dengue studies to improve antibody-based diagnostic tests for Zika and address unanswered questions about the emerging virus’s epidemiology.
Streamline qPCR for Better Data
Streamlining qPCR Through Standardization
The Scientist Creative Services Team, Bio-Rad Laboratories | May 4, 2022
The importance of standardization for research and diagnostic result reproducibility
New Lyme Disease Test Developed by Summer Student
Jenny Rood | Aug 1, 2016
The high schooler was studying cancer biomarkers in a George Mason University lab when her familial experiences with Lyme disease sparked an idea.
Banking on Blood Tests
Jyoti Madhusoodanan | Apr 1, 2016
How close are liquid biopsies to replacing current diagnostics?
Improve qPCR Efficiency and Reproducibility
The Components of Effective qPCR
The Scientist Creative Services Team, Bio-Rad Laboratories | Apr 18, 2022
Putting the pieces together for molecular diagnostics and infectious disease research
FDA: Lab Tests Can Cause Harm
Tracy Vence | Nov 17, 2015
The US Food and Drug Administration cites cases in which laboratory-developed tests “may have caused or have caused actual harm to patients.”
Exomes in the Clinic
Tracy Vence | Oct 21, 2014
Two teams report molecular diagnosis rates of 25 percent sequencing separate sets of patients with undiagnosed, suspected genetic conditions.
Biomarkers on the Brain: From Sequencing to Functional Imaging
Biomarkers on the Brain: From Sequencing to Functional Imaging
The Scientist Creative Services Team | Nov 16, 2021
An expert panel will discuss biomarker development for brain disorders and considerations for their clinical use.
High-Tech Yogurt Could Detect Disease
Molly Sharlach | Oct 16, 2014
Nanoparticle-producing bacteria may simplify the diagnosis of cancer and other medical conditions.
IDing Cancer with 3-D Genomics
Tracy Vence | May 7, 2014
In a proof-of-principle study, scientists show that the three-dimensional shape of a cancer cell genome can reliably classify subtypes of human leukemia.
One Size Does Not Fit All: Pharmacogenomics in Precision Medicine
The Scientist Creative Services Team | Feb 10, 2021
Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.
Next Generation: Cancer Cell Protein Profiling
Abby Olena | Jan 15, 2014
Antibody barcoding allows scientists and clinicians to analyze protein expression in small amounts of cancer tissue.